MSL – ATTR/Cardiovascular - Texas

AstraZeneca•Wilmington, DE

5d•Onsite

About The Position

At AstraZeneca, we turn ideas into life-changing medicines. Working here means being entrepreneurial, thinking big, and collaborating to make the impossible a reality. We focus on the power of science to address unmet patient needs worldwide. We commit to areas where we can truly change the course of medicine and bring ambitious new ideas to life. As an Amyloidosis (ATTR) Medical Science Liaison (MSL), you’ll play a pivotal role in channeling our scientific expertise to positively impact patient care. About the BioPharmaceuticals Business Unit (BBU) The BBU develops and drives therapeutic area and product strategies that address unmet patient needs globally. We integrate commercial, market access, medical, digital, and corporate functions to drive scientific innovation and commercial excellence in respiratory, cardiovascular, renal, and diabetes disease areas. Why This Role Matters As an ATTR MSL, you will be part of AstraZeneca’s mission to transform clinical practice through science and technology. You’ll partner with healthcare professionals to reduce acute episodes, disease complications, hospital admissions, and premature death. Through innovation, leadership, and sustainability, we put patients first. What You’ll Do In this field-based role covering Dallas, Houston, San Antonio, Austin, and surrounding areas you will: Engage and build relationships: Develop and maintain strong connections with heart failure specialists, cardiologists, and key opinion leaders (KOLs) in cardiovascular and amyloid disease areas Scientific exchange and insights: Collect, analyze, and share evidence-based insights while leveraging territory relationships to accelerate knowledge transfer and influence clinical practice ATTR-CM expertise: Apply prior experience or meaningful exposure to ATTR cardiomyopathy in field activities and translate complex scientific data into clear, clinician-ready insights Education and collaboration: Support clinician education, deliver presentations, and provide clinical guidance at regional and national meetings Patient-focused impact: Identify opportunities to improve patient outcomes and provide actionable insights to internal teams Regulatory and product knowledge: Respond to inquiries with clear, balanced scientific information while ensuring compliance with regulatory and company standards Continuous learning: Stay current on disease state management, emerging therapies, and the competitive landscape Development Opportunities Structured onboarding and continuous learning programs Exposure to clinical development activities and therapeutic brand strategies Opportunities to lead projects within the medical team and develop leadership skills over time

Requirements

Advanced degree in a clinical or scientific field (MD, PharmD, PhD, NP, PA)
1–2 years of clinical experience in ATTR, Heart Failure, Cardiology and/or pharmaceutical experience with exposure to cardiovascular or amyloidosis disease areas, including KOL engagement, scientific exchange, and territory-based field activities
Understanding of healthcare delivery systems, payer structures, and treatment pathways
Clinical experience in the relevant therapeutic area and ability to build professional relationships
Strong communication skills to convey complex scientific information clearly
Demonstrated ability to lead projects and influence cross-functional teams
Knowledge of regulatory and compliance requirements related to medical affairs
Ability to travel 50–70% (varies by geography), including weekends and overnights

Nice To Haves

2+ years of pharmaceutical industry experience / previous MSL experience in ATTR
Rare Disease and/or Cardiology experience
Ability to build and leverage relationships to influence outcomes that improve patient care

Responsibilities

Engage and build relationships: Develop and maintain strong connections with heart failure specialists, cardiologists, and key opinion leaders (KOLs) in cardiovascular and amyloid disease areas
Scientific exchange and insights: Collect, analyze, and share evidence-based insights while leveraging territory relationships to accelerate knowledge transfer and influence clinical practice
ATTR-CM expertise: Apply prior experience or meaningful exposure to ATTR cardiomyopathy in field activities and translate complex scientific data into clear, clinician-ready insights
Education and collaboration: Support clinician education, deliver presentations, and provide clinical guidance at regional and national meetings
Patient-focused impact: Identify opportunities to improve patient outcomes and provide actionable insights to internal teams
Regulatory and product knowledge: Respond to inquiries with clear, balanced scientific information while ensuring compliance with regulatory and company standards
Continuous learning: Stay current on disease state management, emerging therapies, and the competitive landscape